Lemuel Aigbivbalu, MD

Projects

Projects per year 2013 2013 2021 2024 2029

• 2 Completed
• 2 Active

Projects per year

Search results

• Active

  A MULTICENTER, OPEN-LABEL, PHASE 1B STUDY TO ASSESS THE PHARMACOKINETICS, SAFETY, AND TOLERABILITY OF SULBACTAM-DURLOBACTAM IN HOSPITALIZED PEDIATRIC PATIENTS FROM BIRTH TO <18 YEARS WHO ARE RECEIVING SYSTEMIC ANTIBIOTIC THERAPY FOR SUSPECTED OR CONFIRM

  Aigbivbalu, L. (PI)

  Entasis Therapeutics ( Award # )

  12/23/24 → 12/22/29

  Project: Research project

• A Multicenter, Open-Label, Pharmacokinetic and Safety Study of Baricitinib in Pediatric Patients from 1 Year to Less than 18 Years Old Hospitalized with COVID-19

  Aigbivbalu, L. (PI)

  Eli Lilly ( Award # )

  10/1/21 → 9/30/26

  Project: Research project

• Completed

  CE01-119: A Phase 1, Open-label, Multi-center Study to Determine the Pharmacokinetics and Safety of Solithromycin as Add-on Therapy in Adolescents with Suspected or Confirmed Bacterial Infection

  Aigbivbalu, L. (PI)

  Duke University ( Award #HHSO100201300009C)

  12/5/13 → 5/23/15

  Project: Research project

• A Phase 1,Open Label, Single Dose Study to Investigate the Pharmacokinetics, Safety and Tolerability of Dalbavancin in Hospitalized Children Aged 3 Months to 11 Years Receiving Standard Intravenous Anti-Infective Treatment for Bacterial Infections

  Aigbivbalu, L. (PI)

  Duke University ( Award # )

  11/13/13 → 11/12/15

  Project: Research project